实践现状:关于在患有慢性病的患者中使用基于的对比剂的ASNR声明
Kirk M Welker1, David Joyner2, Anthony W Kam3
1From the Department of Radiology (K.M.W.), Mayo Clinic, Rochester, Minnesota welker.kirk@mayo.edu.
AJNR. American journal of neuroradiology
|September 16, 2024
概括
美国神经辐射学会 (ASNR) 现在建议在患有慢性病 (CKD) 的患者中使用基于加多的对比剂 (GBCA) 进行神经成像. 第二组GBCA被认为对CKD患者是安全的,因此无需进行常规安全措施.
科学领域:
- 放射学 放射学是一门学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医疗成像医学成像
背景情况:
- 2006年在慢性脏病 (CKD) 患者中使用加多基对比剂 (GBCA) 确定了原性系统性纤维化 (NSF) 风险.
- 放射学实践实施了安全措施,大大减少了NSF的发生率.
- 随后的研究发现,与II组GBCA相关的最小的未经证实的NSF病例.
研究的目的:
- 审查CKD患者GBCA安全性的最新证据.
- 根据当前的研究,修订MRI对比剂的管理准则.
- 为神经成像对照在CKD中的使用提供建议.
主要方法:
- 评估了过去5年的系统审查和元分析.
- 美国神经辐射学会 (ASNR) 标准和准则委员会进行了审查.
- 根据综合证据制定了建议.
主要成果:
- 新的研究表明,在神经成像中,II组GBCA对CKD患者是安全的.
- 当医学上有指示时,不再建议扣留II组GBCA.
- 如果仅使用II组GBCA,则可以停止像功能检查这样的常规安全措施.
结论:
- 美国神经科学研究所建议不要在CKD患者中保留II组GBCA用于神经成像.
- 建议在仅使用II组GBCA时停止安全措施.
- 此更新旨在改善CKD患者的诊断成像访问.
相关概念视频
Radiological Investigation I: X-ray and CT
218
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
218
Imaging Studies I: CT and MRI
201
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
201
Factors Affecting Renal Clearance: Renal Impairment
62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Renal Clearance
790
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
790
Renal Drug Clearance: Comparison Between Renal Excretion Methods
83
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
83


